IDENTIFICATION OF GAUCHER DISEASE CARRIERS - GLUCOCEREBROSIDASE ANTIGEN AND DNA ANALYSIS

被引:3
作者
LACERDA, L [1 ]
AMARAL, O [1 ]
PINTO, R [1 ]
AERTS, J [1 ]
MIRANDA, MCS [1 ]
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,EC SLATER INST BIOCHEM RES,1105 AZ AMSTERDAM,NETHERLANDS
来源
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY | 1993年 / 50卷 / 02期
关键词
D O I
10.1006/bmmb.1993.1061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Detection of Portuguese carriers for Gaucher disease with urine samples as a source of enzyme was carried out using an immunological procedure employing an anti-glucocerebrosidase monoclonal antibody and by DNA analysis for the presence of the two glucocerebrosidase mutations most frequently found in Portuguese Gaucher patients. Patients, obligate and putative carriers, and individuals unrelated to patients were analyzed. It was found that the vast majority of carriers for the two tested mutations (N370S and L444P), as well as obligate carriers for as yet unidentified mutations, could be distinguished from control subjects with this relatively easy and economic immunological procedure. Furthermore, results obtained for control subjects suggested a high frequency of carriers for the N370S mutation in the Portuguese population. It is concluded that this procedure may be useful in mass screening for carrier detection prior to DNA analysis, particularly in the study of non-Ashkenazi populations in which a significant number of mutations associated with Gaucher disease remain unidentified. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:190 / 196
页数:7
相关论文
共 23 条
[1]  
AERTS JM, BIOCHEM J, V269, P93
[2]   THE IDENTIFICATION OF TYPE-1 GAUCHER DISEASE PATIENTS, ASYMPTOMATIC CASES AND CARRIERS IN THE NETHERLANDS USING URINE SAMPLES - AN EVALUATION [J].
AERTS, JMFG ;
SAMIRANDA, MC ;
DELACERDA, LW ;
VANWEELY, S ;
DONKERKOOPMAN, W ;
BROUWERKELDER, B ;
JANSEN, DC ;
VANLEEUWEN, M ;
SCHRAM, AW ;
TSIAPARA, A ;
TAGER, JM .
CLINICA CHIMICA ACTA, 1991, 203 (2-3) :349-362
[3]  
AMARAL O, BIOCHEM MED METAB B, V49, P97
[4]   MONOCLONAL-ANTIBODIES AGAINST HUMAN BETA-GLUCOCEREBROSIDASE [J].
BARNEVELD, RA ;
TEGELAERS, FPW ;
GINNS, EI ;
VISSER, P ;
LAANEN, EA ;
BRADY, RO ;
GALJAARD, H ;
BARRANGER, JA ;
REUSER, AJJ ;
TAGER, JM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1983, 134 (03) :585-589
[5]  
Barranger J. A., 1989, METABOLIC BASIS INHE, P1677
[6]   GAUCHER DISEASE - NEW MOLECULAR APPROACHES TO DIAGNOSIS AND TREATMENT [J].
BEUTLER, E .
SCIENCE, 1992, 256 (5058) :794-799
[7]   IDENTIFICATION OF THE 2ND COMMON JEWISH GAUCHER DISEASE MUTATION MAKES POSSIBLE POPULATION-BASED SCREENING FOR THE HETEROZYGOUS STATE [J].
BEUTLER, E ;
GELBART, T ;
KUHL, W ;
SORGE, J ;
WEST, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10544-10547
[8]   METABOLISM OF GLUCOCEREBROSIDES .2. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHERS DISEASE [J].
BRADY, RO ;
KANFER, JN ;
SHAPIRO, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1965, 18 (02) :221-&
[9]  
GRABOWSKI GA, 1982, GAUCHER DISEASE CENT, P573
[10]  
Kolodny EH, 1982, GAUCHER DISEASE CENT, P33